시장보고서

상품코드

1709478

만성 정맥 폐색 치료 시장 : 제품 유형별, 치료 유형별, 진단별, 최종 용도별, 국가별, 지역별, 세계 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)

Chronic Venous Occlusions Treatment Market, By Product Type, By Treatment Type, By Diagnosis, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

발행일: 2025년 04월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 303 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

만성 정맥 폐색 치료시장 규모는 2024년 72억943만 달러로 평가되었고, 2025년부터 2032년까지 연평균 복합 성장률(CAGR) 5.80%로 성장할것으로 예상됩니다.

만성 정맥 폐색 치료 시장 - 시장 역학

정맥 질환의 유병률의 상승과 기술의 진보가 만성 정맥 폐색 치료 시장의 성장을 견인

만성정맥부전과 심부정맥혈전증 등 정맥질환의 유병률 상승과 저침습치료기술의 진보가 만성 정맥 폐색 치료시장의 성장을 크게 견인하고 있습니다. 정맥질환은 세계 성인인구의 약 30%가 병을 앓고 있으며, 고령화와 좌식 생활 스타일이 부담증의 원인이 되고 있습니다. 또한 연간 60만 건 이상의 정맥 혈전 색전증이 새롭게 진단되고 있습니다. 생체 흡수 스텐트와 개선된 혈전 용해 기술과 같은 혁신은 치료 결과를 향상시키고 있으며, 신흥 경제국의 의료 인프라를 개선하기 위한 정부 이니셔티브는 시장 확장을 위한 새로운 기회를 창출하고 있습니다. 그러나, 치료비의 상승과 지방에서의 고도 의료 액세스의 제한이라고 하는 과제는 여전히 보급의 중요한 장벽이 되고 있습니다.

만성 정맥 폐색 치료 시장 - 주요 인사이트력

우리 리서치 애널리스트의 분석에 따르면 세계 시장은 예측 기간(2025-2032년)에 약 5.80%의 연평균 복합 성장률(CAGR)로 매년 성장할 것으로 추정됩니다.

제품 유형별로, 정맥 스텐트와 항응고제는 2024년에 가장 큰 시장 점유율을 나타낼 것으로 예측됩니다.

치료 유형별로 정맥 내 절제와 혈전 용해 요법이 2024년 주요 치료 유형이었습니다.

진단별로는 듀플렉스 초음파가 2024년의 주요 진단이었습니다.

지역별로는 북미가 2024년 매출을 이끌었습니다.

만성 정맥 폐색 치료 시장 - 세분화 분석 :

세계의 만성 정맥 폐색 치료 시장은 제품 유형, 치료 유형, 진단, 최종 용도 및 지역에 따라 세분화됩니다.

시장은 제품 유형에 따라 네 가지 범주로 나뉩니다. 즉, 압박 스타킹, 정맥 스텐트, 항응고제, 경화 요법제 등입니다.

시장은 치료 유형에 따라 두 가지로 분류됩니다. 즉, 압박 요법, 약물 요법, 정맥 내 소작 요법, 외과 적 개입, 혈전 용해 요법입니다.

만성 정맥 폐색 치료 시장 - 지리적 통찰

만성 정맥 폐색 치료 시장은 건강 관리 인프라, 질병 유병률, 선진 치료 접근 등의 차이로 인해 큰 지역 차이를 볼 수 있습니다. 조기 도입에 힘입어 시장을 독점하고 있으며, 미국은 심부정맥혈전증이나 만성정맥부전의 증례 증가로 큰 점유율을 차지하고 있습니다. 시어티브에 견인되고 그 뒤를 이어가고 있습니다. 아시아태평양은 의료비 증가, 의료 시설 접근성 개선, 정맥 질환에 대한 의식이 높아짐에 따라 중국과 인도와 같은 국가가 견인역으로 급속한 성장이 예상됩니다. 한편, 라틴아메리카와 중동, 아프리카는 의료 액세스가 제한되어 있는 등의 과제에 직면하고 있지만, 의료 인프라에 대한 투자와 저침습 치료의 채용 증가를 통해 점차 시장에서의 존재를 확대하고 있습니다.

만성 정맥 폐색 치료 시장 - 경쟁 구도 :

만성 정맥 폐색 치료시장은 기존의 의료기기기업, 신흥기업, 기술 혁신과 시장 확대를 목적으로 한 전략적 제휴의 존재에 의해 특징지어지는 경쟁 구도를 특징으로 합니다. Medtronic, Boston Scientific, 그리고 Philips Healthcare 등의 주요 기업이 시장을 독점하고 광범위한 제품 포트폴리오와 강력한 유통망을 활용하여 경쟁력을 유지하고 있습니다. 소기업과 신흥기업도 틈새 부문와 비용 효율적인 치료에 주력함으로써 견인력을 늘리고 있습니다. 인정과 임상시험은 경쟁력학 형성에 중요한 역할을 하고 있으며, 각 사는 엄격한 안전성과 효능의 기준을 충족하기 위해 노력하고 있습니다.

소개
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 네덜란드
- 스웨덴
- 러시아
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 중국
- 인도
- 일본
- 한국
- 호주
- 인도네시아
- 태국
- 필리핀
- 기타
라틴아메리카(LATAM)
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카(MEA)
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 튀르키예
- 알제리
- 이집트
- 기타

제12장 주요 벤더 분석 - 만성 정맥 폐색 치료 업계

경쟁 대시보드
- Competitive Benchmarking
- Competitive Positioning
기업 프로파일
- Abbott Laboratories
- AngioDynamics, Inc.
- Becton, Dickinson and Company
- Boston Scientific Corporation
- BTG International Ltd.
- Cardinal Health, Inc.
- Cook Medical
- Endologix, Inc.
- Koninklijke Philips NV
- LeMaitre Vascular, Inc.
- Medtronic plc
- Merit Medical Systems, Inc.
- Stryker Corporation
- Teleflex Incorporated
- Terumo Corporation
- Vascular Solutions, Inc.
- Others

제13장 애널리스트의 전방위적 전망

SHW 25.05.23

REPORT HIGHLIGHT

Chronic Venous Occlusions Treatment Market size was valued at US$ 7,209.43 Million in 2024, expanding at a CAGR of 5.80% from 2025 to 2032.

The Chronic Venous Occlusions (CVO) Treatment Market focuses on addressing blockages in the venous system, often caused by deep vein thrombosis or chronic venous insufficiency, through interventions like angioplasty, stenting, and thrombolysis. Increasing prevalence of venous diseases, advancements in minimally invasive surgical techniques, and rising awareness about early diagnosis are propelling market growth, with over 30% of adults estimated to suffer from some form of venous disorder globally. However, high treatment costs and limited access to advanced healthcare in developing regions act as significant restraints. Opportunities lie in the development of innovative bioabsorbable stents and the expansion of telemedicine for post-treatment care, particularly in underserved areas. Additionally, the growing aging population, which is more susceptible to venous disorders, further underscores the potential for market expansion.

Chronic Venous Occlusions Treatment Market- Market Dynamics

Rising Prevalence of Venous Disorders and Technological Advancements to Drive Chronic Venous Occlusions Treatment Market Growth

The rising prevalence of venous disorders, such as chronic venous insufficiency and deep vein thrombosis, coupled with advancements in minimally invasive treatment technologies, is significantly driving the growth of the Chronic Venous Occlusions (CVO) Treatment Market. According to the World Health Organization (WHO), venous diseases affect approximately 30% of the global adult population, with aging populations and sedentary lifestyles contributing to the increasing burden. For instance, the National Institutes of Health (NIH) reports that over 600,000 new cases of venous thromboembolism are diagnosed annually in the United States alone. Innovations like bioabsorbable stents and improved thrombolysis techniques are enhancing treatment outcomes, while government initiatives to improve healthcare infrastructure in emerging economies are creating new opportunities for market expansion. However, challenges such as high treatment costs and limited access to advanced care in rural areas remain critical barriers to widespread adoption.

Chronic Venous Occlusions Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.80% over the forecast period (2025-2032)

Based on product type segmentation, Venous stents and anticoagulants was predicted to show maximum market share in the year 2024

Based on Treatment Type segmentation, Endovenous ablation and thrombolytic therapy was the leading Treatment Type in 2024

Based on Diagnosis segmentation, Duplex Ultrasound was the leading Diagnosis in 2024

On the basis of region, North America was the leading revenue generator in 2024

Chronic Venous Occlusions Treatment Market- Segmentation Analysis:

The Global Chronic Venous Occlusions Treatment Market is segmented on the basis of Product Type, Treatment Type, Diagnosis, End-User, and Region.

The market is divided into four categories based on product type: Compression stockings, venous stents, anticoagulants, sclerotherapy agents, and others. Venous stents and anticoagulants dominate due to their efficacy in treating severe occlusions, while compression stockings remain popular for early-stage management and preventive care.

The market is divided into two categories based on Treatment Type: Compression therapy, pharmacological treatment, endovenous ablation, surgical interventions, and thrombolytic therapy. Endovenous ablation and thrombolytic therapy are widely used due to their minimally invasive nature and effectiveness, while compression therapy remains widely used for early-stage management.

Chronic Venous Occlusions Treatment Market- Geographical Insights

The Chronic Venous Occlusions (CVO) Treatment Market exhibits significant regional variation, driven by differences in healthcare infrastructure, disease prevalence, and access to advanced treatments. North America dominates the market, supported by a high prevalence of venous disorders, robust healthcare systems, and early adoption of innovative technologies, with the U.S. accounting for a substantial share due to rising cases of deep vein thrombosis and chronic venous insufficiency. Europe follows closely, driven by aging populations and government-funded healthcare initiatives, particularly in countries like Germany and the UK. The Asia-Pacific region is expected to witness rapid growth due to increasing healthcare expenditure, improving access to medical facilities, and a growing awareness of venous diseases, with countries like China and India leading the way. Meanwhile, Latin America and the Middle East & Africa face challenges such as limited healthcare access but are gradually expanding their market presence through investments in healthcare infrastructure and rising adoption of minimally invasive treatments.

Chronic Venous Occlusions Treatment Market- Competitive Landscape:

The Chronic Venous Occlusions (CVO) Treatment Market features a competitive landscape characterized by the presence of established medical device companies, emerging players, and strategic collaborations aimed at innovation and market expansion. Key players such as Medtronic, Boston Scientific, and Philips Healthcare dominate the market, leveraging their extensive product portfolios and strong distribution networks to maintain a competitive edge. These companies are actively investing in research and development to introduce advanced solutions like bioabsorbable stents and next-generation thrombolysis devices. Smaller firms and startups are also gaining traction by focusing on niche segments and cost-effective treatments. Strategic partnerships, mergers, and acquisitions are common, as companies aim to enhance their technological capabilities and geographic reach. Additionally, regulatory approvals and clinical trials play a crucial role in shaping the competitive dynamics, with players striving to meet stringent safety and efficacy standards. The market's competitive intensity is further fueled by increasing demand for minimally invasive treatments and the growing prevalence of venous disorders worldwide.

Recent Developments:

In June 2024, Philips has launched the Duo Venous Stent System, a device to treat symptomatic venous outflow obstruction in chronic venous insufficiency (CVI) patients. The system, comprised of two stents, is designed for the unique challenges of venous anatomy and demonstrated safety and efficacy in the VIVID study.

In July 2024, Inari expanded its device portfolio with FDA-cleared VenaCore, a minimally invasive thrombectomy catheter for peripheral vasculature. Featuring a notched coring element and collapsible handle, VenaCore efficiently debulks and removes tough venous occlusions, enhancing treatment for complex vascular blockages.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CHRONIC VENOUS OCCLUSIONS TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Abbott Laboratories
AngioDynamics, Inc.
Becton, Dickinson and Company
Boston Scientific Corporation
BTG International Ltd.
Cardinal Health, Inc.
Cook Medical
Endologix, Inc.
Koninklijke Philips N.V.
LeMaitre Vascular, Inc.
Medtronic plc
Merit Medical Systems, Inc.
Stryker Corporation
Teleflex Incorporated
Terumo Corporation
Vascular Solutions, Inc.
Others

GLOBAL CHRONIC VENOUS OCCLUSIONS TREATMENT MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

Compression Stockings
Venous Stents
Anticoagulants
Sclerotherapy Agents
Others

GLOBAL CHRONIC VENOUS OCCLUSIONS TREATMENT MARKET, BY TREATMENT TYPE- MARKET ANALYSIS, 2019 - 2032

Compression Therapy
Pharmacological Treatment
Endovenous Ablation
Surgical Interventions
Thrombolytic Therapy

GLOBAL CHRONIC VENOUS OCCLUSIONS TREATMENT MARKET, BY DIAGNOSIS- MARKET ANALYSIS, 2019 - 2032

Duplex Ultrasound
Venography
Magnetic Resonance Venography
Others

GLOBAL CHRONIC VENOUS OCCLUSIONS TREATMENT MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Home Care Settings

GLOBAL CHRONIC VENOUS OCCLUSIONS TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Chronic Venous Occlusions Treatment Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Chronic Venous Occlusions Treatment Market Snippet by Product Type
- 2.1.2. Chronic Venous Occlusions Treatment Market Snippet by Treatment Type
- 2.1.3. Chronic Venous Occlusions Treatment Market Snippet by Diagnosis
- 2.1.4. Chronic Venous Occlusions Treatment Market Snippet by End-User
- 2.1.5. Chronic Venous Occlusions Treatment Market Snippet by Country
- 2.1.6. Chronic Venous Occlusions Treatment Market Snippet by Region
2.2. Competitive Insights

3. Chronic Venous Occlusions Treatment Key Market Trends

3.1. Chronic Venous Occlusions Treatment Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Chronic Venous Occlusions Treatment Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Chronic Venous Occlusions Treatment Market Opportunities
3.4. Chronic Venous Occlusions Treatment Market Future Trends

4. Chronic Venous Occlusions Treatment Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Chronic Venous Occlusions Treatment Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Chronic Venous Occlusions Treatment Market Landscape

6.1. Chronic Venous Occlusions Treatment Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Chronic Venous Occlusions Treatment Market - By Product Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
- 7.1.2. Compression Stockings
- 7.1.3. Venous Stents
- 7.1.4. Anticoagulants
- 7.1.5. Sclerotherapy Agents
- 7.1.6. Others

8. Chronic Venous Occlusions Treatment Market - By Treatment Type

8.1. Overview
- 8.1.1. Segment Share Analysis, By Treatment Type, 2024 & 2032 (%)
- 8.1.2. Compression Therapy
- 8.1.3. Pharmacological Treatment
- 8.1.4. Endovenous Ablation
- 8.1.5. Surgical Interventions
- 8.1.6. Thrombolytic Therapy

9. Chronic Venous Occlusions Treatment Market - By Diagnosis

9.1. Overview
- 9.1.1. Segment Share Analysis, By Diagnosis, 2024 & 2032 (%)
- 9.1.2. Duplex Ultrasound
- 9.1.3. Venography
- 9.1.4. Magnetic Resonance Venography
- 9.1.5. Others

10. Chronic Venous Occlusions Treatment Market - By End-User

10.1. Overview
- 10.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
- 10.1.2. Hospitals
- 10.1.3. Ambulatory Surgical Centers
- 10.1.4. Specialty Clinics
- 10.1.5. Home Care Settings

11. Chronic Venous Occlusions Treatment Market- By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. Chronic Venous Occlusions Treatment Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. Chronic Venous Occlusions Treatment Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.9. UK
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.9.4. UK Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  - 11.3.9.5. UK Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.3.9.6. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.10. France
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.10.4. France Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  - 11.3.10.5. France Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.3.10.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.11. Italy
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.11.4. Italy Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  - 11.3.11.5. Italy Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.3.11.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.12. Spain
  - 11.3.12.1. Overview
  - 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.12.4. Spain Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  - 11.3.12.5. Spain Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.3.12.6. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.13. The Netherlands
  - 11.3.13.1. Overview
  - 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.13.4. The Netherlands Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  - 11.3.13.5. The Netherlands Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.3.13.6. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Overview
  - 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.3.14.6. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.15. Russia
  - 11.3.15.1. Overview
  - 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.15.4. Russia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  - 11.3.15.5. Russia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.3.15.6. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.16. Poland
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.16.4. Poland Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  - 11.3.16.5. Poland Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.3.16.6. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.17. Rest of Europe
  - 11.3.17.1. Overview
  - 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.17.4. Rest of the Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  - 11.3.17.5. Rest of the Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Chronic Venous Occlusions Treatment Key Manufacturers in Asia Pacific
- 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.5. APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
- 11.4.6. APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 11.4.7. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.8. China
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.8.4. China Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  - 11.4.8.5. China Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.4.8.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.9. India
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.9.4. India Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  - 11.4.9.5. India Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.4.9.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.13. Indonesia
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.13.4. Indonesia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  - 11.4.13.5. Indonesia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.4.13.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.14. Thailand
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.14.4. Thailand Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  - 11.4.14.5. Thailand Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.4.14.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.16.4. Rest of APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  - 11.4.16.5. Rest of APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
- 11.5.1. Overview
- 11.5.2. Chronic Venous Occlusions Treatment Key Manufacturers in Latin America
- 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.5. LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
- 11.5.6. LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 11.5.7. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
- 11.6.1. Overview
- 11.6.2. Chronic Venous Occlusions Treatment Key Manufacturers in Middle East and Africa
- 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.5. MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
- 11.6.6. MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 11.6.7. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.14.4. Rest of MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  - 11.6.14.5. Rest of MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
  - 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Chronic Venous Occlusions Treatment Industry

12.1. Competitive Dashboard
- 12.1.1. Competitive Benchmarking
- 12.1.2. Competitive Positioning
12.2. Company Profiles
- 12.2.1. Abbott Laboratories
- 12.2.2. AngioDynamics, Inc.
- 12.2.3. Becton, Dickinson and Company
- 12.2.4. Boston Scientific Corporation
- 12.2.5. BTG International Ltd.
- 12.2.6. Cardinal Health, Inc.
- 12.2.7. Cook Medical
- 12.2.8. Endologix, Inc.
- 12.2.9. Koninklijke Philips N.V.
- 12.2.10. LeMaitre Vascular, Inc.
- 12.2.11. Medtronic plc
- 12.2.12. Merit Medical Systems, Inc.
- 12.2.13. Stryker Corporation
- 12.2.14. Teleflex Incorporated
- 12.2.15. Terumo Corporation
- 12.2.16. Vascular Solutions, Inc.
- 12.2.17. Others

13. 360 Degree AnalystView

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us